Biotech

Latest Articles

Ultragenyx adjusts gene therapy application to dial up effectiveness

.A minority of patients taking Ultragenyx Pharmaceutical's Wilson health condition genetics therapy ...

Biopharma cutback rate maintains in Q3: Fierce Biotech review

.As summer months heat energy looks to cool winds, wishes that this year will deliver prevalent sect...

J &amp J drops stage 2 dengue candidate in most recent shift from vaccines

.Johnson &amp Johnson's deprioritization of its infectious disease pipeline has actually declared an...

Relay loses 10% of personnel after earlier discharges in July

.Preciseness medication biotech Relay Therapeutics is shedding around 10% of its workforce in effort...

Pentixapharm credit ratings $22M IPO to loan radiopharma trials

.Pentixapharm has introduced nearly 20 thousand euros ($ 22 million) from an IPO, with the German bi...

Lundbeck faucets Charles Waterway for AI-enabled neuro drug discovery

.Lundbeck has actually tapped Charles Waterway Laboratories' artificial intelligence capacities to a...

Big pharma, biotech 'won't always be cooperative' in AI: S&ampP

.Large Pharma is committing heavily in AI to slash development timelines and foster advancement. But...

I &amp I biotech Triveni elevates $115M for preclinical antitoxins

.Triveni Biography has roped in $115 thousand in set B funds to accelerate preclinical antibody prog...

IGM rotates coming from cancer to autoimmune, agitating C-suite

.IGM Biosciences ended in 2013 laying off staff as well as simplifying its cancer pipeline. Currentl...

Shattuck axes CD47 program over unstable efficiency records, gives up 40% of staff as well as drops Ono deal

.Shattuck Labs has knocked an additional nail into the coffin of CD47. After finding a "small" resul...

BioMarin goes Camping outdoors, striking RNA deal with biotech

.BioMarin is adding kindling to the R&ampD fire, attacking a suit with CAMP4 Therapies for liberties...

Cash- strapped Gritstone starts hunt for strategic options as cancer vaccination data underwhelm

.Gritstone bio has introduced bankers to look into "prospective value-maximizing methods" after its ...

Kailera launches along with $400M series A, 4 Mandarin excessive weight medications

.Kailera Therapeutics has actually introduced in to the more and more jampacked being overweight roo...

Metsera associate with Amneal to lock down GLP-1 source

.With very early stage 1 records today out in the wild, metabolic health condition ensemble Metsera ...

Rivus posts information to back up muscle-sparing weight problems medication claims

.Rivus Pharmaceuticals has actually unveiled the data responsible for its stage 2 excessive weight g...

BMS pays out $110M to form T-cell treatment pact, helping Top buy opportunity to improve prioritized pipeline

.Bristol Myers Squibb is spending Excellent Medicine $110 million in advance to create reagents for ...

Generate gains one more $1B-plus Major Pharma alliance

.Novartis has inked a package possibly worth more than $1 billion along with Flagship-founded Genera...

Metsera GLP-1 records cut uncovers 7.5% weight reduction at 36 times

.Recently debuted Metsera is actually unfolding some period 1 data for its GLP-1 receptor agonist, d...

Flagship hopes biotechs group to Mirai to increase hereditary medications

.In the middle of the genetic medications branches race, Main Pioneering is actually revealing a bra...

BioAge eyes $180M coming from IPO, personal placement for obesity trials

.BioAge Labs is actually checking out around $180 thousand in preliminary proceeds coming from an IP...